Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 4344-4348, August 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Leon, M. P.
Right arrow Articles by Roncucci, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Leon, M. P.
Right arrow Articles by Roncucci, L.

Familial Aggregation of Tumors in the Three-Year Experience of a Population-based Colorectal Cancer Registry1

Maurizio Ponz de Leon2, Romano Sassatelli, Carla Sacchetti, Gianni Zanghieri, Alessandra Scalmati and Luca Roncucci

The Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Istituto di Patologia Medica, Università di Modena, Modena, Italy

The familial occurrence of tumors has been investigated in 389 subjects with colorectal cancer by reviewing the clinical data and the genealogical tree of all patients registered in 1984–1986, in the Local Health District, for malignancies of the large bowel.

Among first-degree relatives of the registered patients there were 89 cases of colorectal cancer as opposed to 19 in a hospital-based control group matched for age and sex [odds ratio (OR), 7.5, P < 0.001]. This excess of neoplasms among relatives was particularly evident in siblings (60 versus 7, OR 14.7, P < 0.001) but it was observed also in parents (27 versus 12, OR 4.2, P < 0.01). Besides colorectal cancer there was no significant excess of other types of tumor in case families, whereas lung tumors tended to be more frequent in control relatives (32 versus 17). Almost half of the registered patients (182 out of 389) had one or more cases of cancer of any sites among relatives; similarly, in 68 there were one or more relatives affected by (or deceased for) colorectal cancer. Moreover, in 27 patients (7.0%) there were at least three cancers of any sites among relatives and in 15 the excess (two or more) was limited to neoplasms of the large bowel. In patients without or with only one neoplasm among relatives, cancers were mainly located in the left colon; however, cancer of the right colon became relatively more frequent in patients with two or more tumors in close relatives.

In conclusion, the present study suggests that in approximately 15–20% of patients registered for colorectal cancer one or more first-degree relatives are affected by neoplasms of the large bowel. This familial occurrence of intestinal malignancies (but not of tumors of other organs) strongly suggests a genetic susceptibility to colorectal cancer in a fraction of these patients. Moreover, in a further subgroup of individuals (approximately 5% of all cases) the familial aggregation of two or more cases of colorectal cancer among relatives (besides the proband) and the frequent location of tumors in the right colon make the diagnosis of Lynch syndrome extremely probable.

1 This work has been supported by Grant 1970 (15.03.1986) of the Regione Emilia Romagna. Dr. Sacchetti and Dr. Roncucci were supported by the Lega Italiana per la Lotta contro i Tumori, sezione di Modena. Parts of this work have been presented at the 46th Meeting of the British Society of Gastroenterology (Newcastle-upon-Tyne, UK, September 18–20, 1985) and at the 9th Meeting of the European Association for Cancer Research (Helsinki, Finland, May 31–June 3, 1987).

2 To whom requests for reprints should be addressed, at Istituto di Pathologia Medica, Policlinico, via del Pozzo, 71, 41100—Modena, Italy.

Received 6/16/88. Revised 10/21/88. Revised 1/30/89. Revised 4/ 5/89. Accepted 4/17/89.




This article has been cited by other articles:


Home page
Ann OncolHome page
M. Ponz de Leon, M. Marino, P. Benatti, G. Rossi, M. Menigatti, M. Pedroni, C. Di Gregorio, L. Losi, F. Borghi, A. Scarselli, et al.
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry
Ann. Onc., June 1, 2004; 15(6): 940 - 946.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
P. M. Brauer, G. E. McKeown-Eyssen, V. Jazmaji, A. G. Logan, D. F. Andrews, D. Jenkins, N. Marcon, F. Saibil, L. Cohen, H. Stern, et al.
Familial Aggregation of Diabetes and Hypertension in a Case-Control Study of Colorectal Neoplasia
Am. J. Epidemiol., October 15, 2002; 156(8): 702 - 713.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. T. Lynch and J. Lynch
Lynch Syndrome: Genetics, Natural History, Genetic Counseling, and Prevention
J. Clin. Oncol., November 1, 2000; 18(90001): 19s - 31.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. J. Peel, A. Ziogas, E. A. Fox, M. Gildea, B. Laham, E. Clements, R. D. Kolodner, and H. Anton-Culver
Characterization of Hereditary Nonpolyposis Colorectal Cancer Families From a Population-Based Series of Cases
J Natl Cancer Inst, September 20, 2000; 92(18): 1517 - 1522.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J M D WHEELER, W F BODMER, and N J M. MORTENSEN
DNA mismatch repair genes and colorectal cancer
Gut, July 1, 2000; 47(1): 148 - 153.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
Z. Q. YUAN, N. WONG, W. D FOULKES, L. ALPERT, F. MANGANARO, C. ANDREUTTI-ZAUGG, R. IGGO, K. ANTHONY, E. HSIEH, M. REDSTON, et al.
A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening
J. Med. Genet., October 1, 1999; 36(10): 792 - 793.
[Full Text]


Home page
GutHome page
M P. de Leon, M Pedroni, P Benatti, A Percesepe, C Di Gregorio, M Foroni, G Rossi, M Genuardi, G Neri, F Leonardi, et al.
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis
Gut, July 1, 1999; 45(1): 32 - 38.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A.-M. Codori, G. M. Petersen, D. L. Miglioretti, E. K. Larkin, M. T. Bushey, C. Young, J. D. Brensinger, K. Johnson, J. A. Bacon, and S. V. Booker
Attitudes toward Colon Cancer Gene Testing: Factors Predicting Test Uptake
Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 345 - 351.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. W. Vernon, E. R. Gritz, S. K. Peterson, C. A. Perz, S. Marani, C. I. Amos, and W. F. Baile
Intention to Learn Results of Genetic Testing for Hereditary Colon Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 353 - 360.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S R Brown, P J Finan, and D T Bishop
Are relatives of patients with multiple HNPCC spectrum tumours at increased risk of cancer?
Gut, November 1, 1998; 43(5): 664 - 668.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S R Brown, P J Finan, L Cawkwell, P Quirke, and D T Bishop
Frequency of replication errors in colorectal cancer and their association with family history
Gut, October 1, 1998; 43(4): 553 - 557.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.